Delivery Order SPE2DB22D3501-SPE2DB25FUH58

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of SPRYCEL 70 MG TABLET 60S, a prescription medication. The contract, valued at $13,211.27, is a Firm Fixed Price Delivery Order with a completion date of June 11, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order valued at $3,634.46 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of SPRYCEL 20 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 26, 2024 and is a firm fixed price type contract. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $16,629.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a Firm Fixed Price delivery order for the supply of SPRYCEL 100 MG TABLET 30S pharmaceutical products, with a period of performance through July 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $5,322.67 firm-fixed-price delivery order is for the supply of SPRYCEL 100 MG TABLET 30S, a prescription medication. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, to provide a comprehensive range of...
This federal contract award, with an ID of SPE2DB22D1103|SPE2DB25FTDP4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,525.79, is for the delivery of SPRYCEL 80 MG TABLET 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of January 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,153.03 Firm Fixed Price Delivery Order is for the supply of SPRYCEL 100 MG TABLET 30S, a prescription medication. The award has an ultimate completion date of February 5, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,512.99 firm fixed-price delivery order is for the supply of SPRYCEL 100 MG TABLET 30S, a pharmaceutical product, with a period of performance through June 24, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as...
This federal contract award, valued at $7,319.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the supply of SPRYCEL 50 MG TABLET 60S, a pharmaceutical product, to support military healthcare...
This federal contract award, valued at $10,835.50, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for SPRYCEL 50 MG TABLET 60S, a pharmaceutical product, with a completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the prescription drug SPRYCEL 100 MG TABLET 30S to the Department of Defense (DoD) and its affiliated healthcare systems. The $93,146.38 delivery order has a firm fixed price and an ultimate completion date of April 24, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUH58
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,183.98 Firm Fixed Price Delivery Order contract is for the supply of SPRYCEL 100 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of January 28, 2025.

AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies.

This contract award was not designated with any set-aside requirements, indicating open competition.

Generated 4/28/25, 9:55 AM